Sign in
International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update
Journal article   Open access  Peer reviewed

International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update

Pushpa Narayanaswami, Donald B Sanders, Gil Wolfe, Michael Benatar, Gabriel Cea, Amelia Evoli, Nils Erik Gilhus, Isabel Illa, Nancy L Kuntz, Janice Massey, …
Neurology, Vol.96(3), pp.114-122
2021-01-19
PMID: 33144515

Abstract

Rituximab - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Thymectomy Humans Immune Checkpoint Inhibitors - therapeutic use Immunosuppressive Agents - therapeutic use Myasthenia Gravis - therapy Disease Management Methotrexate - therapeutic use Myasthenia Gravis - drug therapy Consensus Myasthenia Gravis - surgery
url
https://doi.org/10.1212/WNL.0000000000011124View
Published (Version of record) Open

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Highly Cited Paper 
Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.203 Neuromuscular Disorders
1.203.1325 Myasthenia Gravis
Web Of Science research areas
Clinical Neurology
ESI research areas
Neuroscience & Behavior

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details